IL-32 is a host protective cytokine against Mycobacterium tuberculosis in differentiated THP-1 human macrophages.
about
Interleukin 32 (IL-32) contains a typical α-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1.Interleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10.Paradoxical effects of constitutive human IL-32{gamma} in transgenic mice during experimental colitis.Inhibition of nuclear factor-kappa B activation decreases survival of Mycobacterium tuberculosis in human macrophages.Inflammation-dependent secretion and splicing of IL-32{gamma} in rheumatoid arthritis.Elevated interleukin-32 expression is associated with Helicobacter pylori-related gastritis.Caspase-3-independent apoptotic pathways contribute to interleukin-32γ-mediated control of Mycobacterium tuberculosis infection in THP-1 cellsIL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease.Human IL-32 expression protects mice against a hypervirulent strain of Mycobacterium tuberculosis.Differential expression of interleukin-32 in chronic rhinosinusitis with and without nasal polypsIFNG-mediated immune responses enhance autophagy against Mycobacterium tuberculosis antigens in patients with active tuberculosis.NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosy.Enhanced susceptibility to lipopolysaccharide-induced arthritis and endotoxin shock in interleukin-32 alpha transgenic mice through induction of tumor necrosis factor alphaCytokines and microbicidal molecules regulated by IL-32 in THP-1-derived human macrophages infected with New World Leishmania species.Decreased severity of collagen antibody and lipopolysaccharide-induced arthritis in human IL-32β overexpressed transgenic mice.The expression of interleukin-32 is activated by human cytomegalovirus infection and down regulated by hcmv-miR-UL112-1Interleukin-32-induced thymic stromal lymphopoietin plays a critical role in macrophage differentiation through the activation of caspase-1 in vitro.De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes.Mycobacterium tuberculosis PPE32 promotes cytokines production and host cell apoptosis through caspase cascade accompanying with enhanced ER stress response.Novel insights into the biology of interleukin-32.TB or not TB: that is no longer the question.Interleukin-32γ suppresses allergic airway inflammation in mouse models of asthma.Animal models in tuberculosis research - where is the beef?Role of interleukin-32 in Helicobacter pylori-induced gastric inflammation.Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.Curcumin enhances human macrophage control of Mycobacterium tuberculosis infection.Role of interleukin-32 in the mechanism of chronic inflammation in IgG4-related disease and as a predictive biomarker for drug-free remission.Dendritic Cell-Derived IL-32α: A Novel Inhibitory Cytokine of NK Cell Function.Interleukin-32β ameliorates metabolic disorder and liver damage in mice fed high-fat diet.IL-32 is a molecular marker of a host defense network in human tuberculosis.IL-32-PAR2 axis is an innate immunity sensor providing alternative signaling for LPS-TRIF axis.Oxidative stress induced interleukin-32 mRNA expression in human bronchial epithelial cells.Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients.Neuroinflammatory and Amyloidogenic Activities of IL-32β in Alzheimer's Disease.Interleukin-32α promotes the proliferation of multiple myeloma cells by inducing production of IL-6 in bone marrow stromal cells.Subtyping of polyposis nasi: phenotypes, endotypes and comorbidities.Human Interleukin-32γ Plays a Protective Role in an Experimental Model of Visceral Leishmaniasis in Mice.Toll-like receptor 4-mediated expression of interleukin-32 via the c-Jun N-terminal kinase/protein kinase B/cyclic adenosine monophosphate response element binding protein pathway in chronic rhinosinusitis with nasal polyps.Role of interleukin-32 in cancer biology.The Biology and Role of Interleukin-32 in Tuberculosis
P2860
Q30411120-470D706D-C89A-483D-A9E2-8BE43D27F807Q33633481-AC38E662-6955-4EDD-8DA6-9EB1B0C30B41Q34396945-382358CE-E06C-4344-B01B-EF4D6E5EC519Q34698213-D3D9517C-F664-4FE6-9F71-AB39154DFE14Q34720467-4BFD2D5E-1891-4220-9E3D-40AA2BE0F4CAQ35122065-CE647804-BBFA-4211-9BAA-7C7A7231EA2DQ35147724-665FA27A-6313-4E55-9FBD-1EF16EA04BE2Q35469357-C4E33E38-0CA8-480E-8CC0-7C84BA83270DQ35549372-998A3A07-60DB-43F2-9221-392B97E83C85Q35605921-C41A3FCA-E84D-4395-9D2F-4380B32310EEQ35852762-FC7A0B69-EA8A-4748-BE15-1F59FCD1A9C2Q35948586-46D7E1F2-9C68-45D5-8F8D-F5C3865401F7Q36246023-F694CBCF-EAE3-4425-B8F6-5D46B4B66ECFQ36291428-3E14B716-3848-4448-B966-C10917CD299EQ36629365-DA564ED2-A4FF-4F5E-B6B3-8C26B7E63249Q36686444-544B2549-BF34-448B-ADB9-A908E011D9D3Q36907662-B04EFAFE-9520-48D4-A235-46ACE3F58332Q37584726-7ABCB712-BD6F-452E-B96E-A8DAFDF8751EQ37687168-F4923BA6-A0CC-4133-B2CA-560AAB8301B9Q38086768-1FEDC010-4B1E-498A-B4D8-3C5F65C8298EQ38166990-28FA7273-1674-4F70-A76A-0EA0C16CF9D0Q38443719-C87C5978-9F06-46CC-B768-1C036077B84AQ38527417-634C51A8-4406-48A8-B15D-B2EB0C690601Q39297849-FAE30418-F402-40FC-BD35-E15FBD77A847Q39580319-1EF2852B-8770-4855-A83E-73A7DFDD1BC7Q40741808-AE3E04E5-9347-4766-A519-EB4CEE14F0ABQ40997230-C594E2E0-9F3E-4523-9D26-A51974F10729Q41262546-A4D749F1-D93C-471F-9626-C7330C958B8DQ41489654-9AA377DB-16F2-4841-9B31-BF54B1EBE703Q41958265-43B34115-5016-4F41-95AC-88A6C4CE2C21Q41997260-08DC0158-2592-4828-A011-33F43BCB11A9Q42100214-CC358C45-F5A0-43CD-A851-840296826040Q42236150-B7EBAD2E-727D-465A-AB35-181052867B2BQ46700370-F3F9420F-B6BD-45EF-97A5-F1EBAF2E131EQ47158965-885409BC-2715-49EF-BF75-C0605A0BAA83Q52643512-F2E66A0A-E514-4BD4-8DFD-804F49364F87Q52730248-D002296E-4792-4EF7-B23D-026D8EDD30DCQ53100844-974C6A08-A620-4865-B480-68B0C26C37D6Q55264916-2600AEA8-F614-4FD7-A3BB-212831425E6DQ58694023-15AA022F-8209-437D-BACD-ACC69ED0BC9B
P2860
IL-32 is a host protective cytokine against Mycobacterium tuberculosis in differentiated THP-1 human macrophages.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
IL-32 is a host protective cyt ...... iated THP-1 human macrophages.
@en
IL-32 is a host protective cyt ...... iated THP-1 human macrophages.
@nl
type
label
IL-32 is a host protective cyt ...... iated THP-1 human macrophages.
@en
IL-32 is a host protective cyt ...... iated THP-1 human macrophages.
@nl
prefLabel
IL-32 is a host protective cyt ...... iated THP-1 human macrophages.
@en
IL-32 is a host protective cyt ...... iated THP-1 human macrophages.
@nl
P2093
P921
P356
P1476
IL-32 is a host protective cyt ...... iated THP-1 human macrophages.
@en
P2093
Edward D Chan
Mischa T McGibney
Soo-Hyun Kim
Tania Azam
Xiyuan Bai
P304
P356
10.4049/JIMMUNOL.0901913
P407
P577
2010-02-26T00:00:00Z